Contraline
Latest round
- Series B
Last raised
- May 2026
Total raised
- $75M
Investors
- 28
About Contraline
Contraline, Inc.Founded in 2015 and headquartered in Charlottesville, US, Contraline, Inc. specializes in male contraceptive solutions. In June 2026, Contraline, Inc.Contraline specializes in innovative contraceptive solutions, primarily focusing on the development of ADAM™, the first long-lasting implant designed for male contraception. This product functions similarly to intrauterine devices (IUDs) used by women, providing a reversible and effective form of birth control specifically for men. The company's mission is to resolve the limitations faced by traditional contraceptive methods, aiming to enhance user experience.Contraline's revenue model is based on direct-to-consumer sales and partnerships with healthcare providers and family planning clinics. The company generates income through sales of its flagship product, ADAM™, and may also engage in institutional agreements with clinics offering reproductive health services. Though specific pricing plans for ADAM™ are not disclosed, the company's strategy emphasizes direct engagement with end-users to enhance accessibility and adoption of its innovative solution.
Who invested in Contraline
28 investors across 6 rounds
See all investors in Contraline
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Contraline
Who invested in Contraline?
Contraline has 28 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Contraline raised?
Contraline has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Contraline last raise money?
Contraline's most recent round on record is a Series B, in May 2026.
What does Contraline do?
Contraline is a biotechnology company.
Where is Contraline headquartered?
Contraline is headquartered in Charlottesville, US.
Which VCs invest in companies like Contraline?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Contraline's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Contraline? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.